QOMEL

Qomel Company

9600StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Semi-annual (SAR)

1-5

	H2 2025Dec 31, 2025	H1 2025Jun 30, 2025	H2 2024Dec 31, 2024	H1 2024Jun 30, 2024	H2 2023Dec 31, 2023
Operating Summary
Revenue	61.00M	71.24M	65.64M	58.56M	61.44M
Cost of Revenue	44.66M	48.00M	42.56M	38.92M	42.06M
Gross Profit	16.34M	23.24M	23.08M	19.64M	19.38M
SG&A	9.90M	9.19M	8.99M	7.04M	5.99M
Operating Expenses	10.47M	9.19M	9.57M	7.04M	5.99M
Operating Income	5.86M	14.04M	13.51M	12.60M	13.39M
Interest Income	1.09M	—	1.06M	—	—
Interest Expense	—	-3.71M	-1.96M	-1.03M	-0.29M
Other Income/Expense	-818.46K	818.46K	-219.33K	219.33K	-18.74K
Pretax Income	5.82M	11.16M	12.14M	11.79M	13.15M
Income Tax	0.93M	1.09M	1.18M	0.79M	0.77M
Net Income	4.89M	10.07M	10.95M	11.00M	12.38M
EBITDA	5.96M	14.14M	13.56M	12.68M	13.42M
EBIT	5.86M	14.04M	13.51M	12.60M	13.39M
EPS (Basic)	0.88	1.19	1.41	1.76	2.06
EPS (Diluted)	0.88	1.19	1.41	1.76	2.06
Margins & Efficiency
Gross Margin %	+26.8%	+32.6%	+35.2%	+33.5%	+31.5%
EBITDA Margin %	+9.8%	+19.9%	+20.7%	+21.6%	+21.8%
Net Margin %	+8.0%	+14.1%	+16.7%	+18.8%	+20.1%
Revenue & Income
Revenue	61.00M	71.24M	65.64M	58.56M	61.44M
Revenue Growth (YoY)	-7.1%	+21.6%	+6.8%	+33.0%	+61.9%
Interest & Investment Income	1.09M	—	1.06M	—	—
Gain (Loss) on Sale of Assets	0.18K	—	—	—	14.58K
Currency Exchange Gain (Loss)	-318.71K	—	-243.83K	—	52.07K
Expenses & Provisions
Cost of Revenue	44.66M	48.00M	42.56M	38.92M	42.06M
Selling, General & Admin	9.90M	9.19M	8.99M	7.04M	5.99M
Operating Expenses	10.47M	9.19M	9.57M	7.04M	5.99M
Interest Expense	—	-3.71M	-1.96M	-1.03M	-0.29M
Other Non Operating Income (Expenses)	-818.46K	818.46K	-219.33K	219.33K	-18.74K
D&A For EBITDA	99.31K	98.94K	58.94K	75.10K	30.38K
Profitability & Returns
Gross Profit	16.34M	23.24M	23.08M	19.64M	19.38M
EBIT	5.86M	14.04M	13.51M	12.60M	13.39M
EBITDA	5.96M	14.14M	13.56M	12.68M	13.42M
EBT Excluding Unusual Items	5.82M	11.16M	12.14M	11.79M	13.13M
Pretax Income	5.82M	11.16M	12.14M	11.79M	13.15M
Operating Income	5.86M	14.04M	13.51M	12.60M	13.39M
Operating Margin	+9.6%	+19.7%	+20.6%	+21.5%	+21.8%
Profit Margin	+8.0%	+14.1%	+16.7%	+18.8%	+20.1%
Net Income	4.89M	10.07M	10.95M	11.00M	12.38M
Net Income to Common	4.89M	10.07M	10.95M	11.00M	12.38M
Net Income Growth	-55.4%	-8.5%	-11.5%	+111.0%	+101.4%
Income Tax Expense	0.93M	1.09M	1.18M	0.79M	0.77M
Per Share & Capital
EPS (Basic)	0.88	1.19	1.41	1.76	2.06
EPS (Diluted)	0.88	1.19	1.41	1.76	2.06
EPS Growth	-37.5%	-32.4%	-31.4%	+102.3%	—
Dividend Per Share	—	—	—	—	—
Shares Change (YoY)	-0.29	0.35	0.29	0.04	—
Shares Outstanding (Basic)	5.52M	8.48M	7.74M	6.26M	6.00M
Shares Outstanding (Diluted)	5.52M	8.48M	7.74M	6.26M	6.00M
Free Cash Flow	-5.16M	-20.26M	-2.78M	-20.95M	2.28M
Free Cash Flow Margin	-8.5%	-28.4%	-4.2%	-35.8%	+3.7%
Free Cash Flow Per Share	-0.93	-2.39	-0.36	-3.35	0.38

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Semi-annual (SAR)

1-5

	H2 2025Dec 31, 2025	H1 2025Jun 30, 2025	H2 2024Dec 31, 2024	H1 2024Jun 30, 2024	H2 2023Dec 31, 2023
Operating Summary
Revenue	61.00M	71.24M	65.64M	58.56M	61.44M
Cost of Revenue	44.66M	48.00M	42.56M	38.92M	42.06M
Gross Profit	16.34M	23.24M	23.08M	19.64M	19.38M
SG&A	9.90M	9.19M	8.99M	7.04M	5.99M
Operating Expenses	10.47M	9.19M	9.57M	7.04M	5.99M
Operating Income	5.86M	14.04M	13.51M	12.60M	13.39M
Interest Income	1.09M	—	1.06M	—	—
Interest Expense	—	-3.71M	-1.96M	-1.03M	-0.29M
Other Income/Expense	-818.46K	818.46K	-219.33K	219.33K	-18.74K
Pretax Income	5.82M	11.16M	12.14M	11.79M	13.15M
Income Tax	0.93M	1.09M	1.18M	0.79M	0.77M
Net Income	4.89M	10.07M	10.95M	11.00M	12.38M
EBITDA	5.96M	14.14M	13.56M	12.68M	13.42M
EBIT	5.86M	14.04M	13.51M	12.60M	13.39M
EPS (Basic)	0.88	1.19	1.41	1.76	2.06
EPS (Diluted)	0.88	1.19	1.41	1.76	2.06
Margins & Efficiency
Gross Margin %	+26.8%	+32.6%	+35.2%	+33.5%	+31.5%
EBITDA Margin %	+9.8%	+19.9%	+20.7%	+21.6%	+21.8%
Net Margin %	+8.0%	+14.1%	+16.7%	+18.8%	+20.1%
Revenue & Income
Revenue	61.00M	71.24M	65.64M	58.56M	61.44M
Revenue Growth (YoY)	-7.1%	+21.6%	+6.8%	+33.0%	+61.9%
Interest & Investment Income	1.09M	—	1.06M	—	—
Gain (Loss) on Sale of Assets	0.18K	—	—	—	14.58K
Currency Exchange Gain (Loss)	-318.71K	—	-243.83K	—	52.07K
Expenses & Provisions
Cost of Revenue	44.66M	48.00M	42.56M	38.92M	42.06M
Selling, General & Admin	9.90M	9.19M	8.99M	7.04M	5.99M
Operating Expenses	10.47M	9.19M	9.57M	7.04M	5.99M
Interest Expense	—	-3.71M	-1.96M	-1.03M	-0.29M
Other Non Operating Income (Expenses)	-818.46K	818.46K	-219.33K	219.33K	-18.74K
D&A For EBITDA	99.31K	98.94K	58.94K	75.10K	30.38K
Profitability & Returns
Gross Profit	16.34M	23.24M	23.08M	19.64M	19.38M
EBIT	5.86M	14.04M	13.51M	12.60M	13.39M
EBITDA	5.96M	14.14M	13.56M	12.68M	13.42M
EBT Excluding Unusual Items	5.82M	11.16M	12.14M	11.79M	13.13M
Pretax Income	5.82M	11.16M	12.14M	11.79M	13.15M
Operating Income	5.86M	14.04M	13.51M	12.60M	13.39M
Operating Margin	+9.6%	+19.7%	+20.6%	+21.5%	+21.8%
Profit Margin	+8.0%	+14.1%	+16.7%	+18.8%	+20.1%
Net Income	4.89M	10.07M	10.95M	11.00M	12.38M
Net Income to Common	4.89M	10.07M	10.95M	11.00M	12.38M
Net Income Growth	-55.4%	-8.5%	-11.5%	+111.0%	+101.4%
Income Tax Expense	0.93M	1.09M	1.18M	0.79M	0.77M
Per Share & Capital
EPS (Basic)	0.88	1.19	1.41	1.76	2.06
EPS (Diluted)	0.88	1.19	1.41	1.76	2.06
EPS Growth	-37.5%	-32.4%	-31.4%	+102.3%	—
Dividend Per Share	—	—	—	—	—
Shares Change (YoY)	-0.29	0.35	0.29	0.04	—
Shares Outstanding (Basic)	5.52M	8.48M	7.74M	6.26M	6.00M
Shares Outstanding (Diluted)	5.52M	8.48M	7.74M	6.26M	6.00M
Free Cash Flow	-5.16M	-20.26M	-2.78M	-20.95M	2.28M
Free Cash Flow Margin	-8.5%	-28.4%	-4.2%	-35.8%	+3.7%
Free Cash Flow Per Share	-0.93	-2.39	-0.36	-3.35	0.38